Antitumor Trans Platinum Adducts of GMP and AMP
2000
Antitumor Effects of Trans-Platinum Adducts with GMP and AMP
publication
Evidence: moderate
Author Information
Author(s): Yangzhong Liu, Maria F. Sivo, Giovanni Natile, Einar Sletten
Primary Institution: University of Bergen
Hypothesis
The study investigates the binding and antitumor activity of trans-platinum adducts with guanosine monophosphate (GMP) and adenosine monophosphate (AMP).
Conclusion
The trans-platinum adducts exhibit significant binding to GMP and AMP, leading to the formation of various adducts with potential antitumor activity.
Supporting Evidence
- Trans-platinum adducts form monofunctional and bifunctional species with GMP and AMP.
- The binding pattern of trans-platinum is complex and influenced by pH and nucleotide concentration.
- Different adducts exhibit varying stability and reactivity over time.
Takeaway
This study shows that a type of platinum drug can bind to important molecules in our cells and might help fight cancer.
Methodology
The study used HPLC and NMR spectroscopy to analyze the binding of trans-platinum to GMP and AMP.
Want to read the original?
Access the complete publication on the publisher's website